GE HealthCare (NASDAQ: GEHC) reported Q3 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $4.86 billion versus the consensus estimate of $4.87 billion.

GUIDANCE:

GE HealthCare sees FY2024 EPS of $4.25-$4.35, versus prior guidance of $4.20-$4.35 and the consensus of $4.25.

For earnings history and earnings-related data on GE HealthCare (GEHC) click here.